Arcturus Blogging San Diego Venture Capital 
Xconomy
MARCH 2, 2018
The money came from a wide range of backers, not just traditional biotech venture firms. billion, a figure compiled in the Venture Monitor Report. Biotech startups rolled in cash this week. By our count, investors put more than $800 million into life-sciences startups in four days.
Xconomy
FEBRUARY 9, 2018
The top biopharma story of the week involves the fast-moving field of lung cancer, which, as we’ve written previously, has several key trials reading out in 2018. A big domino fell this week: data from a two-drug immunotherapy combination developed by Bristol-Myers Squibb. But the results, touted as positive, left more questions than answers.
Expert insights. Personalized for you.
52 
Let's personalize your content